Characteristic | Value |
---|---|
Country of origin | |
Slovakia | 43 (31) |
Germany | 36 (26) |
The Netherlands | 25 (18) |
Belgium | 24 (17) |
UK | 12 (8) |
Patients | |
Female gender (%) | 78 |
Age, years (mean±SD) | 53±14 |
Disease duration in years (mean±SD) | 14±8 |
Patients currently on GC treatment (%) | 80 |
GC treatment duration in years (mean±SD) | 9±6 |
GC dose in mg prednisone equivalent (mean±SD) | 6.2±3.1 |
Diagnosis | |
Rheumatoid arthritis | 85 (61) |
Systemic lupus erythematosus | 16 (11) |
Polymyalgia rheumatica | 7 (5) |
Other | 32 (23) |
Values are n (%) unless otherwise indicated.